66 results
8-K
CHRS
Coherus Biosciences Inc
26 Dec 23
Other Events
8:49pm
and well-tolerated adhesive. After the dose is administered, the needle automatically retracts, which reduces the risk of needlestick injury.
The approval
DRS
EX-10.9
CHRS
Coherus Biosciences Inc
4 Aug 14
Draft registration statement
12:00am
, the public, the Premises and/or the environment against damage, contamination, injury and/or liability, including, but not limited to, the installation … , but not be limited to, the effects of any contamination or injury to person, property or the environment created or suffered by Lessee, and the cost
DRS
EX-10.8
CHRS
Coherus Biosciences Inc
4 Aug 14
Draft registration statement
12:00am
Commercial General Liability Insurance covering claims of bodily injury, personal injury and property damage arising out of Tenant’s operations and contractual … liability on behalf of itself and all parties claiming by, through or under Tenant; and (d) no Landlord Party shall be liable for any injury or damage
DRS/A
EX-10
nlfttw aqdixlte
5 Aug 14
Draft registration statement (amended)
12:00am
DRS/A
EX-10
gh6ee uhht464
5 Aug 14
Draft registration statement (amended)
12:00am
DRS/A
EX-10
jsx60ec
5 Aug 14
Draft registration statement (amended)
12:00am
DRS/A
EX-10
lny0zwl7yz4
5 Aug 14
Draft registration statement (amended)
12:00am
DRS/A
EX-10
s3z8sypn8 k0
5 Aug 14
Draft registration statement (amended)
12:00am
8-K
EX-2.1
3ib3uof yz4umgl
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
10-Q
m8nu6g0gdrqkbn 8m
15 Dec 14
Quarterly report
12:00am